Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Chronic ghrelin administration restores hippocampal long-term potentiation and ameliorates memory impairment in rat model of Alzheimer's disease.

Eslami M, Sadeghi B, Goshadrou F.

Hippocampus. 2018 Jul 15. doi: 10.1002/hipo.23002. [Epub ahead of print]

PMID:
30009391
2.

MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.

Jeong YO, Shin SJ, Park JY, Ku BK, Song JS, Kim JJ, Jeon SG, Lee SM, Moon M.

Int J Mol Sci. 2018 Jun 18;19(6). pii: E1800. doi: 10.3390/ijms19061800.

3.

Rivastigmine Improves Appetite by Increasing the Plasma Acyl/Des-Acyl Ghrelin Ratio and Cortisol in Alzheimer Disease.

Furiya Y, Tomiyama T, Izumi T, Ohba N, Ueno S.

Dement Geriatr Cogn Dis Extra. 2018 Mar 13;8(1):77-84. doi: 10.1159/000487358. eCollection 2018 Jan-Apr.

4.

The Biased G-Protein-Coupled Receptor Agonism Bridges the Gap between the Insulin Receptor and the Metabolic Syndrome.

Liauchonak I, Dawoud F, Riat Y, Qorri B, Sambi M, Jain J, Kalaydina RV, Mendonza N, Bajwa K, Szewczuk MR.

Int J Mol Sci. 2018 Feb 17;19(2). pii: E575. doi: 10.3390/ijms19020575. Review.

5.

Effect of rivastigmine on plasma butyrylcholine esterase activity and plasma ghrelin levels in patients with dementia in Alzheimer's disease.

Kuroda A, Setoguchi M, Uchino Y, Nagata K, Hokonohara D.

Geriatr Gerontol Int. 2018 Jun;18(6):886-891. doi: 10.1111/ggi.13275. Epub 2018 Feb 14.

PMID:
29441654
6.

Cholinesterases and the fine line between poison and remedy.

Pope CN, Brimijoin S.

Biochem Pharmacol. 2018 Jul;153:205-216. doi: 10.1016/j.bcp.2018.01.044. Epub 2018 Jan 31. Review.

PMID:
29409903
7.

Potential neuroprotective and anti-apoptotic properties of a long-lasting stable analog of ghrelin: an in vitro study using SH-SY5Y cells.

Popelová A, Kákonová A, Hrubá L, Kuneš J, Maletínská L, Železná B.

Physiol Res. 2018 May 4;67(2):339-346. Epub 2018 Jan 5.

8.

Leptin and ghrelin: Sewing metabolism onto neurodegeneration.

de Candia P, Matarese G.

Neuropharmacology. 2018 Jul 1;136(Pt B):307-316. doi: 10.1016/j.neuropharm.2017.12.025. Epub 2017 Dec 15. Review.

PMID:
29248481
9.

Increased Serum Acylated Ghrelin Levels in Patients with Mild Cognitive Impairment.

Cao X, Zhu M, He Y, Chu W, Du Y, Du H.

J Alzheimers Dis. 2018;61(2):545-552. doi: 10.3233/JAD-170721.

10.

Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.

Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S.

Cell Mol Life Sci. 2017 Oct;74(20):3769-3787. doi: 10.1007/s00018-017-2550-9. Epub 2017 Jun 22. Review.

PMID:
28643167
11.

Acyl ghrelin improves cognition, synaptic plasticity deficits and neuroinflammation following amyloid β (Aβ1-40) administration in mice.

Santos VV, Stark R, Rial D, Silva HB, Bayliss JA, Lemus MB, Davies JS, Cunha RA, Prediger RD, Andrews ZB.

J Neuroendocrinol. 2017 May;29(5). doi: 10.1111/jne.12476.

PMID:
28380673
12.

Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes.

Palleria C, Leporini C, Maida F, Succurro E, De Sarro G, Arturi F, Russo E.

Front Neuroendocrinol. 2016 Jul;42:76-92. doi: 10.1016/j.yfrne.2016.07.002. Epub 2016 Aug 9. Review.

PMID:
27521218
13.

Role of metabolism in neurodegenerative disorders.

Procaccini C, Santopaolo M, Faicchia D, Colamatteo A, Formisano L, de Candia P, Galgani M, De Rosa V, Matarese G.

Metabolism. 2016 Sep;65(9):1376-90. doi: 10.1016/j.metabol.2016.05.018. Epub 2016 Jun 7. Review.

PMID:
27506744
14.

Brain metabolism as a modulator of autophagy in neurodegeneration.

Lim Y, Cho H, Kim EK.

Brain Res. 2016 Oct 15;1649(Pt B):158-165. doi: 10.1016/j.brainres.2016.02.049. Epub 2016 Mar 9. Review.

PMID:
26970520
15.

Ghrelin and Neurodegenerative Disorders-a Review.

Shi L, Du X, Jiang H, Xie J.

Mol Neurobiol. 2017 Mar;54(2):1144-1155. doi: 10.1007/s12035-016-9729-1. Epub 2016 Jan 26. Review.

PMID:
26809582
16.

Obestatin promotes proliferation and survival of adult hippocampal progenitors and reduces amyloid-β-induced toxicity.

Gargantini E, Lazzari L, Settanni F, Taliano M, Trovato L, Gesmundo I, Ghigo E, Granata R.

Mol Cell Endocrinol. 2016 Feb 15;422:18-30. doi: 10.1016/j.mce.2015.11.008. Epub 2015 Nov 14.

PMID:
26586206
17.

Adipose Tissue Distribution in Patients with Alzheimer's Disease: A Whole Body MRI Case-Control Study.

Diehl-Wiesenecker E, von Armin CA, Dupuis L, Müller HP, Ludolph AC, Kassubek J.

J Alzheimers Dis. 2015;48(3):825-32. doi: 10.3233/JAD-150426.

PMID:
26402111
18.

Eating behavior in frontotemporal dementia: Peripheral hormones vs hypothalamic pathology.

Ahmed RM, Latheef S, Bartley L, Irish M, Halliday GM, Kiernan MC, Hodges JR, Piguet O.

Neurology. 2015 Oct 13;85(15):1310-7. doi: 10.1212/WNL.0000000000002018. Epub 2015 Sep 16.

19.

Central acylated ghrelin improves memory function and hippocampal AMPK activation and partly reverses the impairment of energy and glucose metabolism in rats infused with β-amyloid.

Kang S, Moon NR, Kim DS, Kim SH, Park S.

Peptides. 2015 Sep;71:84-93. doi: 10.1016/j.peptides.2015.07.005. Epub 2015 Jul 15.

PMID:
26188171
20.

Ghrelin agonist does not foster insulin resistance but improves cognition in an Alzheimer's disease mouse model.

Kunath N, van Groen T, Allison DB, Kumar A, Dozier-Sharpe M, Kadish I.

Sci Rep. 2015 Jun 19;5:11452. doi: 10.1038/srep11452.

Supplemental Content

Loading ...
Support Center